GSK (GSK)

Sector:

Pharma and Biotech

Index:

FTSE 100

1,312.00p
   
  • Change Today:
      12.00p
  • 52 Week High: 1,812.50p
  • 52 Week Low: 1,300.00p
  • Currency: UK Pounds
  • Shares Issued: 4,145.10m
  • Volume: 1,228,891
  • Market Cap: £54,384m
  • RiskGrade: 129
  • Beta: 0.56

Latest ShareCast News

GSK's linerixibat meets primary endpoint

By Iain Gilbert

Date: Tuesday 19 Nov 2024

(Sharecast News) - Drugmaker GSK said on Tuesday that its linerixibat candidate had shown "positive" Phase III results in cholestatic pruritus in primary biliary cholangitis.

London close: Stocks end turbulent week in the red

By Josh White

Date: Friday 15 Nov 2024

(Sharecast News) - London stocks ended Friday in negative territory, weighed down by losses in pharmaceutical shares and a surprise slowdown in UK economic growth during the third quarter.

GSK's Blenrep shows strong survival benefit in myeloma study

By Josh White

Date: Thursday 14 Nov 2024

(Sharecast News) - GSK reported positive results from its phase three 'DREAMM-7' trial on Thursday, highlighting a significant overall survival benefit for 'Blenrep', or belantamab mafodotin, in patients with relapsed or refractory multiple myeloma.

London close: Stocks mixed as Chancellor unveils... 30-Oct-2024 ShareCast
GSK maintains guidance after mixed third quarter 30-Oct-2024 ShareCast
GSK RSV vaccine shows potential to help protect ... 24-Oct-2024 ShareCast
GSK UTI treatment gets FDA priority review status 16-Oct-2024 ShareCast
GSK reports positive results from depemokimab tr... 14-Oct-2024 ShareCast
London close: Stocks red as US inflation, jobles... 10-Oct-2024 ShareCast
London midday: Stocks dip ahead of US inflation ... 10-Oct-2024 ShareCast
GSK's Zantac settlement should give stock a boos... 10-Oct-2024 ShareCast
GSK to pay $2.2bn to settle Zantac lawsuits 10-Oct-2024 ShareCast
GSK's Arexvy provides protection over three RSV ... 08-Oct-2024 ShareCast
GSK meningococcal vaccine receives EMA recommend... 24-Sep-2024 ShareCast
GSK settles two Zantac cases in California 18-Sep-2024 ShareCast
Japan to review GSK's Blenrep drug application 17-Sep-2024 ShareCast
London close: Stocks finish firmer in subdued tr... 13-Sep-2024 ShareCast
GSK to speed up development of blood cancer trea... 13-Sep-2024 ShareCast
GSK reports positive results from mRNA flu vacci... 12-Sep-2024 ShareCast
GSK's herpes vaccine candidate fails to meet pri... 11-Sep-2024 ShareCast
 

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

GSK Market Data

Currency UK Pounds
Share Price 1,312.00p
Change Today 12.00p
% Change 0.92 %
52 Week High 1,812.50p
52 Week Low 1,300.00p
Volume 1,228,891
Shares Issued 4,145.10m
Market Cap £54,384m
Beta 0.56
RiskGrade 129

GSK Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
48.16% below the market average48.16% below the market average48.16% below the market average48.16% below the market average48.16% below the market average
16.00% above the sector average16.00% above the sector average16.00% above the sector average16.00% above the sector average16.00% above the sector average
Price Trend
36.75% below the market average36.75% below the market average36.75% below the market average36.75% below the market average36.75% below the market average
18.37% above the sector average18.37% above the sector average18.37% above the sector average18.37% above the sector average18.37% above the sector average
Income
47.15% above the market average47.15% above the market average47.15% above the market average47.15% above the market average47.15% above the market average
100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average
Growth
5.4% below the market average5.4% below the market average5.4% below the market average5.4% below the market average5.4% below the market average
23.53% above the sector average23.53% above the sector average23.53% above the sector average23.53% above the sector average23.53% above the sector average

What The Brokers Say

Strong Buy 7
Buy 4
Neutral 11
Sell 2
Strong Sell 0
Total 24
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

GSK Dividends

  Latest Previous
  Q3 Q2
Ex-Div 15-Nov-24 15-Aug-24
Paid 09-Jan-25 10-Oct-24
Amount 15.00p 15.00p

Trades for 21-Nov-2024

Time Volume / Share Price
12:44 400 @ 1,312.05p
12:43 952 @ 1,312.00p
12:43 169 @ 1,312.00p
12:43 371 @ 1,312.00p
12:43 162 @ 1,312.00p

GSK Key Personnel

CEO Emma Walmsley

Top of Page